OTC Product News:
A Source of Independent Commentary on Consumer Healthcare

OTC Product News provides forward-looking, independent commentary on how current events impact consumer healthcare companies and their products. Coverage includes editorials, product reviews, and opinion you won’t find elsewhere from expert insiders. Our readership includes stock analysts, marketers, retailers, regulators, journalists, lawyers, and product developers. Our opinion is not biased by stock ownership, vested interest, or business relationships.

Few people in consumer healthcare share the experience as both a scientist and product leader as does our Editor-in-Chief, Donald Kay Riker, Ph.D. As a technology leader at P&G's Personal Healthcare Division, Dr. Riker worked to support over-the-counter products rising to the rank of Associate Director & Research Fellow managing the conduct of over 125 clinical trials of OTC products. Dr. Riker, later recruited by Chattem, Inc a leading acquirer of OTC products, rebuilt and led R&D as its first & last Vice President of R&D & CSO managing all its technical functions. Chattem’s stock price rose 7-fold during his tenure, a period accounting for 88% of the stock’s current value [9/22/09].

Dr. Riker, who trained at Cornell and Yale University School of Medicine, is a member of the Society of Neuroscience, Regulatory Affairs Professionals Society, Licensing Executives Society, American Academy of Allergy, Asthma & Clinical Immunology, American Society of Pharmacology and Experimental Therapeutics, American Society of Clinical Pharmacology & Therapeutics, Infectious Disease Society of America, Drug Information Association, Association of Health Care Journalists, and Sigma Xi. He served on the Consumer Healthcare Product Association’s Scientific Advisory Committee for five years.